| Description: |
Introduction. TRPV4 -associated skeletal dysplasias are a genetically heterogeneous group of autosomal dominant disorders caused by mutations in the TRPV4 gene. TRPV4 contains 16 exons and encodes a Ca2+-permeable transmembrane channel protein. To date, seven nosological forms within this group of skeletal dysplasias have been described. The overall prevalence of these disorders does not exceed 1:1,000,000. The most frequent forms among this group are spondylometaphyseal dysplasia, Kozlowski type (OMIM:184252) and metatropic dysplasia (OMIM:156530). Objective: to describe the clinical and genetic characteristics of Russian patients with skeletal dysplasia caused by previously reported and newly identified mutations in the TRPV4 gene. Methods. A comprehensive examination of 15 children from unrelated families aged 10 days-15 years with clinical and radiological signs of TRPV4-associated skeletal dysplasia was carried out. To specify diagnosis we used genealogical analysis, clinical examination, neurological examination according to a standard method with an assessment of the psycho-emotional sphere, radiography and sequencing a targeted gene panel including 166 genes responsible for the development of hereditary skeletal disorders. Results. Spondylometaphyseal dysplasia, Kozlowski type was diagnosed in 7 and metatropic dysplasia in 8 patients. 7 pathogenic variants in the TRPV4 gene were identified, of which two were novel. As in previously reported cases, two major mutations in the TRPV4 gene were found in Russian patients: p.Arg594His in patients with spondylometaphyseal dysplasia, Kozlowski type and p.Pro799Leu in patients with metatropic dysplasia. Conclusion. Our findings combined with previously reported results suggest the rationale for creating a genetic screening test to detect major mutations in patients with spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia, which have similar clinical and radiological manifestations. Foremost use of this test will improve the molecular diagnostics ... |
| Relation: |
https://www.medgen-journal.ru/jour/article/view/2051/1559; Liedtke W., Choe Y., Martí-Renom M.A., et al. Vanilloid Receptor-Related Osmotically Activated Channel (VR-OAC), a Candidate Vertebrate Osmoreceptor. Cell. 2000;103(3):525-535. doi:10.1016/S0092-8674(00)00143-4; Rock M.J., Prenen J., Funari V.A., et al. Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia. Nat Genet. 2008;40(8):999-1003. doi:10.1038/ng.166; Bieganski T., Beighton P., Lukaszewski M., et al. SMD Kozlowski type caused by p.Arg594His substitution in TRPV4 reveals abnormal ossification and notochordal remnants in discs and vertebrae. Eur J Med Genet. 2017;60(10):509-516. doi:10.1016/j.ejmg.2017.07.004; Nonaka K., Han X., Kato H., et al. Novel gain-of-function mutation of TRPV4 associated with accelerated chondrogenic differentiation of dental pulp stem cells derived from a patient with metatropic dysplasia. Biochem Biophys Reports. 2019;19(April):100648. doi:10.1016/j.bbrep.2019.100648; Leddy H.A., McNulty A.L., Rothfusz N.E., et al. Follistatin in chondrocytes: The link between TRPV4 channelopathies and skeletal malformations. FASEB J. 2014;28(6):2525-2537. doi:10.1096/fj.13-245936; Kozlowski K., Maroteaux P., Spranger J. La dysostose spondylometaphisaire. Press méd. 1967;75:2769-2774.; Dai J., Kim O.H., Cho T.J., et al. Novel and recurrent TRPV4 mutations and their association with distinct phenotypes within the TRPV4 dysplasia family. J Med Genet. 2010;47(10):704-709. doi:10.1136/jmg.2009.075358; Krakow D., Vriens J., Camacho N., et al. Mutations in the Gene Encoding the Calcium-Permeable Ion Channel TRPV4 Produce Spondylometaphyseal Dysplasia, Kozlowski Type and Metatropic Dysplasia. Am J Hum Genet. 2009;84(3):307-315. doi:10.1016/j.ajhg.2009.01.021; Maroteaux P., Spranger J., Wiedemann H.R. Metatrophic dwarfism. Arch Kinderheilkd. 1966;173(3):211-226.; Nishimura G., Lausch E., Savarirayan R., et al. TRPV4-associated skeletal dysplasias. Am J Med Genet Part C Semin Med Genet. 2012;160 C(3):190-204. doi:10.1002/ajmg.c.31335; Ürel-Demir G., Şimşek-Kiper P.Ö., Öncel İ., Utine G.E., Haliloğlu G., Boduroğlu K. Natural history of TRPV4-Related disorders: From skeletal dysplasia to neuromuscular phenotype. Eur J Paediatr Neurol. 2021;32:46-55. doi:10.1016/j.ejpn.2021.03.011; Kannu P., Aftimos S., Mayne V., Donnan L., Savarirayan R. Metatropic dysplasia: Clinical and radiographic findings in 11 patients demonstrating long-term natural history. Am J Med Genet Part A. 2007;143A(21):2512-2522. doi:10.1002/ajmg.a.31941; Geneviève D., Le Merrer M., Feingold J., Munnich A., Maroteaux P., Cormier-Daire V. Revisiting metatropic dysplasia: Presentation of a series of 19 novel patients and review of the literature. Am J Med Genet Part A. 2008;146(8):992-996. doi:10.1002/ajmg.a.32191; Nemec S.F., Cohn D.H., Krakow D., Funari V.A., Rimoin D.L., Lachman R.S. The importance of conventional radiography in the mutational analysis of skeletal dysplasias (the TRPV4 mutational family). Pediatr Radiol. 2012;42(1):15-23. doi:10.1007/s00247-011-2229-6; Cho T.J., Matsumoto K., Fano V., et al. TRPV4-pathy manifesting both skeletal dysplasia and peripheral neuropathy: A report of three patients. Am J Med Genet Part A. 2012;158 A(4):795-802. doi:10.1002/ajmg.a.35268; Faye E., Modaff P., Pauli R., Legare J.Combined Phenotypes of Spondylometaphyseal Dysplasia-Kozlowski Type and Charcot-Marie-Tooth Disease Type 2C Secondary to a TRPV4 Pathogenic Variant. Mol Syndromol. 2019;10(3):154-160. doi:10.1159/000495778; Richards S., Aziz N., Bale S., et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-424. doi:10.1038/GIM.2015.30; Andreucci E., Aftimos S., Alcausin M., et al. TRPV4 related skeletal dysplasias: a phenotypic spectrum highlighted byclinical, radiographic, and molecular studies in 21 new families. Orphanet J Rare Dis. 2011;6(1):1-8. doi:10.1186/1750-1172-6-37.; O’Conor C.J., Leddy H.A., Benefield H.C., Liedtke W.B., Guilak F. TRPV4-mediated mechanotransduction regulates the metabolic response of chondrocytes to dynamic loading. Proc Natl Acad Sci USA. 2014;111(4):1316-1321. doi:10.1073/pnas.1319569111; Nilius B., Voets T. The puzzle of TRPV4 channelopathies. EMBO Rep. 2013;14(2):152-163. doi:10.1038/embor.2012.219; Camacho N., Krakow D., Johnykutty S., et al. Dominant TRPV4 mutations in nonlethal and lethal metatropic dysplasia. Am J Med Genet Part A. 2010;152A(5):1169-1177. doi:10.1002/ajmg.a.33392 |
| Rights: |
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). ; Авторы, публикующие статьи в данном журнале, соглашаются на следующее:Авторы сохраняют за собой автороские права и предоставляют журналу право первой публикации работы, которая по истечении 6 месяцев после публикации автоматически лицензируется на условиях Creative Commons Attribution License , которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в этом журнале.Авторы имеют право размещать их работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу (См. The Effect of Open Access). |